Minerva Surgical, Inc.
Minerva Surgical, Inc. (UTRS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · UTRS · as of Jun 8, 2026
Activity summary
Buy transactions
4
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Minerva Surgical, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
UTRS insider buying and selling by quarter
UTRS insider selling · UTRS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
UTRS executive sell shares · UTRS board member insider trading · UTRS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 9, 2023 | NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner | Purchase | 24,437,927 | $5.00M⚡ | Form 4 |
| May 2, 2022 | Skalnyi Evgueni V. VP Medical Affairs | Award | 49,755 | — | Form 4 |
| May 2, 2022 | Filloux Dominique J. COO | Award | 60,198 | — | Form 4 |
| May 2, 2022 | Jung Joel R CFO | Award | 60,198 | — | Form 4 |
| May 2, 2022 | Clapper David M President and CEO | Award | 229,732 | — | Form 4 |
| Jul 19, 2022 | Sung Derrick Director | Award | 86,956 | $200K | Form 4 |
| Jun 10, 2022 | Behbahani Ali Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | JAFFE ROSS A MD Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | Renzi David Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | Hunt Niquette L. Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | Coste Catherine Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | Anderson Jill Director | Award | 49,792 | $120K | Form 4 |
| Dec 15, 2021 | Skalnyi Evgueni V. VP Medical Affairs | Award | 20,250 | — | Form 4 |
| Dec 15, 2021 | Jung Joel R CFO | Award | 24,500 | — | Form 4 |
| Dec 15, 2021 | Filloux Dominique J. COO | Award | 24,500 | — | Form 4 |
| Dec 15, 2021 | Clapper David M President and CEO | Award | 93,500 | — | Form 4 |
| Dec 15, 2021 | Clapper David M President and CEO · Director | Award | 93,500 | — | Form 4 |
| Dec 13, 2021 | Clapper David M President and CEO · Director | Purchase | 25,000 | $123K | Form 4 |
| Oct 26, 2021 | Behbahani Ali Director | Other | 3,306 | — | Form 4 |
| Oct 26, 2021 | Behbahani Ali Director | Other | 4,196 | — | Form 4 |
| Oct 26, 2021 | Behbahani Ali Director | Other | 704 | — | Form 4 |
| Oct 26, 2021 | Behbahani Ali Director | Other | 281 | — | Form 4 |
| Oct 26, 2021 | NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner | Purchase | 1,300,000 | $15.60M⚡ | Form 4 |
| Oct 26, 2021 | NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner | Other | 3,503,021 | — | Form 4 |
| Oct 26, 2021 | NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner | Other | 3,409,709 | — | Form 4 |
NEW ENTERPRISE ASSOCIATES 13 LP
10 percent owner
Date
Feb 9
Shares
24,437,927
Price
$0.20
Value
$5.00M ⚡
Clapper David M
President and CEO · Director
Date
Dec 15
Shares
93,500
Price
—
Value
—
Clapper David M
President and CEO · Director
Date
Dec 13
Shares
25,000
Price
$4.94
Value
$123K
NEW ENTERPRISE ASSOCIATES 13 LP
10 percent owner
Date
Oct 26
Shares
1,300,000
Price
$12.00
Value
$15.60M ⚡
NEW ENTERPRISE ASSOCIATES 13 LP
10 percent owner
Date
Oct 26
Shares
3,503,021
Price
—
Value
—
NEW ENTERPRISE ASSOCIATES 13 LP
10 percent owner
Date
Oct 26
Shares
3,409,709
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About UTRS insider trading
UTRS insider trades
Minerva Surgical, Inc. (UTRS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including UTRS. Over the past 12 months, 0 insiders have filed transactions with the SEC. UTRS insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Minerva Surgical, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
UTRS insider trading · 5 questionsThe insiders of Minerva Surgical, Inc. (UTRS) include executives and directors such as UTRS, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026